Research Interests
arthritis
,
immunology/allergy/inflammatio
,
minority health issues
,
women's health issues
Recent Publications
Kalin Y, Qiang C, Reilly CM, Cann JA, Rhonda BD, Olson EN, Garcia B, Mishra NA.
An epigenetic switch involving chromatin modifier HDAC9 in T cells links to lupus pathogenesis in MRL/Ipr mice [abstract]. J Dermatol.
2010;
37(Suppl 1):35.
Furie R, Stohl W, Ginzler EM, Becker M, Mishra N, Chatham W, Merrill JT, Weinstein A, McCune WJ, Zhong J, et al.
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Res Ther.
2009;
10(5):art. R109.
Burger KL, Mishra N, Seals D.
Tks5 and macrophage podosome formation [abstract]. Clin Exp Metastasis.
2009;
26(7):869.
Mishra N, Hammer G, inventors; Wake Forest University Health Sciences, assignee.
Method of treating immune diseases. United States patent US 7,557,141. 2009 July 7.
2009;
():.
Lu X, Kovalev GI, Chang H, Kallin E, Knudsen G, Xia L, Mishra N, Ruiz P, Li E, Su L, Zhang Y.
Inactivation of NuRD component Mta2 causes abnormal T cell activation and lupus-like autoimmune disease in mice. J Biol Chem.
2008;
283(20):13825-33.
Zhu X, Lee J-Y, Timmins JM, Brown JM, Boudyguina E, Mulya A, Gebre AK, Willingham MC, Mishra N, Parks JS, et al.
Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem.
2008;
283(34):22930-41.
Sodhi R, Mishra N.
Selective toll-like receptor agonist combinations synergistically trigger inflammatory mediators in macrophages, which can be inhibited by histone deacetylase inhibition [abstract]. Arthritis Rheum.
2008;
58(9 Suppl):S185.
Garcia BA, Hake SB, Diaz RL, Kauer M, Morris SA, Recht J, Shabanowitz J, Mishra N, Strahl BD, Allis CD, Hunt DF.
Organismal differences in post-translational modifications in histones H3 and H4. J Biol Chem.
2007;
282(10):7641-7655.
Atwood T, Carter C, Zhu JM, Mishra N.
Monitoring neuropsychiatric symptoms in Mrl/lpr lupus mouse model with proton magnetic resonance spectroscope [abstract]. Arthritis Rheum.
2006;
54(9):S622.
Mishra N, Keiger K, Labourier E.
MicroRNA signature in human lupus [abstract]. Arthritis Rheum.
2006;
54(9 Suppl):S753.
Mishra N, Keiger K, Labourier E.
Microrna, innate immunity and lupus [abstract]. Arthritis Rheum.
2006;
54(9 Suppl):S39.
Mishra N, Parks J, Rankin C, Clair R.
Histone deacetylase inhibitors decrease macrophage foam cell formation and stabilize atherosclerotic plaques by multiple mechanisms [abstract]. Arthritis Rheum.
2006;
54(9 Suppl):S580.
Snowhite I, Mishra N.
Histone hypermethylation is an indicator of epigenetic plasticity in activated B lymphocytes [abstract]. Arthritis Rheum.
2006;
54(9 Suppl):S41.
Snowhite I, Mishra N.
Histone hypermethylation is an indicator of epigenetic plasticity in activated B lymphocytes [abstract]. Arthritis Rheum.
2006;
54(9 Suppl):S69.
Sodhi R, Mishra N.
Selective toll-like receptor agonist combinations synergistically trigger inflammatory mediators in macrophages, which can be inhibited by histone deacetylase inhibition [abstract]. Arthritis Rheum.
2006;
54(9 Suppl):S43.
Sodhi R, Mishra N.
Selective toll-like receptor agonist combinations synergistically trigger inflammatory mediators in macrophages, which can be inhibited by histone deacetylase inhibition [abstract]. Arthritis Rheum.
2006;
54(9 Suppl):S635.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.